Dental Research / 21.05.2026

[caption id="attachment_73889" align="aligncenter" width="500"]why-regular-dental-care-is-important.jpg Photo by Gustavo Fring[/caption] Historically, medical and dental care have been treated as separate disciplines in the minds of many patients. Most people associate dental visits primarily with cavity prevention, fresh breath, and achieving a bright, confident smile. However, modern clinical research paints a much broader and more complex picture of why oral hygiene is so critical. The human mouth is a literal gateway to the entire body, and neglecting its care can lead to a cascade of medical issues that extend far beyond tooth decay. Establishing a consistent routine with a reliable local dental spot for preventative screenings and professional cleans is actually one of the most effective ways to protect yourself against long-term, chronic systemic inflammation. The mechanism behind this whole-body impact comes down to the immune system's biological response to bacterial overgrowth. When plaque is allowed to accumulate and harden into tartar, it creates a highly protected environment where harmful bacteria thrive along and beneath the gumline. This bacterial invasion triggers an immediate immune response, causing localised inflammation known as gingivitis. If left untreated by a professional, this early-stage condition progresses into periodontitis. Periodontitis is a severe infection that breaks down the soft tissue and bone supporting the teeth, creating pockets where even more bacteria can rapidly multiply.
Dental Research / 19.05.2026

Most people only think about their teeth when something hurts. A twinge. A sensitivity. A filling that feels loose. Then the appointment gets booked, the problem gets fixed, and life moves on until the next issue surfaces. It is understandable. But it misses something important. Your mouth is connected to your heart, your lungs, your blood sugar, and your immune response. Researchers have been mapping these connections for decades, yet most people never hear about them in a routine check-up.

<p>Most people only think about their teeth when something hurts. A twinge. A sensitivity. A filling that feels loose. Then the appointment gets booked, the problem gets fixed, and life moves on until the next issue surfaces.</p> <p>It is understandable. But it misses something important. Your mouth is connected to your heart, your lungs, your blood sugar, and your immune response. Researchers have been mapping these connections for decades, yet most people never hear about them in a routine check-up.</p> <!--more--> <p style="text-align: center;">[ IMAGE 1 ]</p> <hr /> <h2><strong>Your Mouth and Your Heart Have More in Common Than You Think</strong></h2> <p>The mouth hosts hundreds of bacterial species. In a healthy mouth, they coexist without causing problems. When the balance shifts, certain bacteria become destructive. They inflame gum tissue — and that inflammation does not stay put.</p> <p>Studies in cardiovascular medicine have found consistent associations between gum disease and elevated heart disease risk. The mechanism is surprisingly direct: bacteria from infected gum tissue enter the bloodstream and travel to arterial walls. Researchers have actually found oral bacteria inside arterial plaque samples. That shifted the conversation from statistical association to something far more specific.</p> <p>Diabetes adds another layer. People with poorly controlled blood sugar tend to have more severe gum disease, and untreated gum disease appears to make blood sugar harder to regulate in return. It runs both ways. Respiratory health is also gaining attention — bacteria from the mouth have been linked to pneumonia and lung infections, particularly in older adults. In pregnancy, gum disease has been associated with preterm birth and low birth weight, and some health systems now recommend dental check-ups as standard prenatal care.</p> <hr /> <h2><strong>The Inflammation Factor Nobody Talks About</strong></h2> <p>Short-term inflammation is useful — it is the body defending itself. Chronic, low-grade inflammation that drags on for months or years is something else entirely. It sits at the root of heart disease, type 2 diabetes, certain cancers, autoimmune disorders, and cognitive decline.</p> <p>Advanced gum disease is a chronic inflammatory condition. The gums become a persistent source of immune activation, and the chemicals produced — called cytokines — circulate through the body. This is why dental health is no longer just about avoiding cavities. It is about managing one genuine contributor to body-wide inflammation.</p> <p>Gum disease is largely preventable and responds well to treatment. Adults who have drifted away from regular dental care often find that re-establishing it is one of the more impactful decisions they can make. Finding a <a href="https://www.andrewgronowdentalcare.com/locations/brighton/" target="_blank" rel="noopener">dentist in Brighton</a> or a trusted local practice and booking that overdue check-up is a reasonable first step. Not perfection — just professional oversight back in the picture.</p> <p style="text-align: center;">[ IMAGE 2 ]</p> <hr /> <h2><strong>Why Childhood Sets the Trajectory</strong></h2> <p>There is a concept in medicine called the critical window — a period in development when habits and exposures have an outsized effect on long-term outcomes. For oral health, that window opens early. Children who see a dentist regularly from a young age get more than clean teeth. They get comfortable with the environment, and that matters more than most parents realise.</p> <p>Dental anxiety stops many adults from seeking timely care, and a significant amount of that anxiety traces back to early experiences. Primary teeth matter too. They hold space in the jaw for permanent teeth, support speech development, and allow children to eat without pain. When lost too early through decay or infection, they disrupt everything that follows.</p> <p>There is a social dimension as well. Children with visible decay or dental pain often hold back — they avoid smiling, eat less comfortably at school, and stay quiet in class. Getting children into a supportive, child-focused environment early makes a genuine difference. Families who want that specialist approach will find that a dedicated <a href="https://www.dentalsuite.com.au/childrens-dentistry/" target="_blank" rel="noopener">kids dentist Newtown</a> or a similarly focused local practice offers both clinical expertise and the patient manner that makes dental visits manageable rather than dreaded.</p> <p style="text-align: center;">[ IMAGE 3 ]</p> <hr /> <h2><strong>What Good Daily Habits Actually Look Like</strong></h2> <p>Brushing twice a day with fluoride toothpaste is still the foundation. Two minutes is the clinical recommendation — most people do around 45 seconds. A simple phone timer changes this more than any gadget will. Electric toothbrushes consistently outperform manual ones in the research, particularly along the gumline.</p> <p>Flossing clears the contact points between teeth that bristles cannot reach — precisely where decay and gum disease most often begin. If flossing feels awkward, interdental brushes are easier and equally effective. Diet matters more than most people expect, but perhaps not in the way they think. Frequency of sugar exposure is more damaging than total intake. Each sugary encounter triggers an acid attack on enamel lasting around 20 minutes — sipping a soft drink across three hours is far harder on teeth than something sweet eaten once with a meal.</p> <p>Stress is the overlooked factor. It contributes to grinding and clenching during sleep, which wears enamel and can fracture teeth over time. A dentist can spot the signs early and recommend a night guard before real damage accumulates.</p> <hr /> <h2><strong>Why Waiting Almost Always Costs More</strong></h2> <p>A small cavity caught early takes minutes to treat. Left alone, it reaches the nerve — meaning root canal treatment. Left longer still, the tooth may not be salvageable at all. Then comes the extraction, the bone loss, the shifting of adjacent teeth, and eventually the conversation about implants or bridges. At every stage the cost increases. The treatment that costs least and causes least discomfort is always the earliest one.</p> <p>Gum disease follows the same pattern. Early-stage gingivitis reverses with a professional clean and better home care. Advanced periodontitis involves bone loss that cannot be restored, only managed. The only thing separating those two outcomes is usually how long treatment was delayed.</p> <hr /> <h2><strong>Rethinking What Dental Care Is Actually For</strong></h2> <p>Your mouth is not separate from your health — it is part of it. Treating dental care as optional, or as something to deal with only when things go wrong, ignores what the evidence has been building toward for years. For adults, that means a regular check-up rhythm with a practice you trust. For parents, it means introducing dental visits early, keeping them calm and low-key, and not letting your own anxieties pass to your children.</p> <p>The research keeps deepening and the connections between oral health and the rest of the body keep getting clearer. Taking care of your mouth is, increasingly, one of the more straightforward things you can do for your overall health.</p> <hr /> <p style="font-size: 13px; color: #666; background: #f0f0f0; border: 1px solid #d8d8d8; padding: 14px 18px;"><strong>Disclaimer:</strong> The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Some links are sponsored. Products, services and providers are not warranted or endorsed by MedicalResearch.com or Eminent Domains Inc. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website.</p>

Your Mouth and Your Heart Have More in Common Than You Think

The mouth hosts hundreds of bacterial species. In a healthy mouth, they coexist without causing problems. When the balance shifts, certain bacteria become destructive. They inflame gum tissue — and that inflammation does not stay put. Studies in cardiovascular medicine have found consistent associations between gum disease and elevated heart disease risk. The mechanism is surprisingly direct: bacteria from infected gum tissue enter the bloodstream and travel to arterial walls. Researchers have actually found oral bacteria inside arterial plaque samples. That shifted the conversation from statistical association to something far more specific. Diabetes adds another layer. People with poorly controlled blood sugar tend to have more severe gum disease, and untreated gum disease appears to make blood sugar harder to regulate in return. It runs both ways. Respiratory health is also gaining attention — bacteria from the mouth have been linked to pneumonia and lung infections, particularly in older adults. In pregnancy, gum disease has been associated with preterm birth and low birth weight, and some health systems now recommend dental check-ups as standard prenatal care.
Heart Disease / 10.03.2026

Global Destination for Advanced Heart Care Cardiovascular disease remains one of the leading causes of mortality worldwide, making access to timely and high-quality cardiac care critically important. In recent years, patients from many countries — including the United States — have increasingly looked beyond their local healthcare systems for advanced treatment options. One destination gaining international attention is Tel Aviv Sourasky Medical Center (Ichilov), widely recognized as a leading cardiology hospital in Israel. Located in the heart of Tel Aviv, Ichilov has built a strong reputation for providing cutting-edge cardiology in Israel, combining advanced medical technologies with internationally trained specialists and a patient-centered approach. Each year, thousands of international patients travel to the medical center for heart treatment in Israel, seeking highly specialized procedures, innovative therapies, and the opportunity to receive treatment without long waiting lists. This unique combination of medical expertise, efficiency, and international experience has made Ichilov one of the most prominent destinations for cardiovascular disease treatment in Israel.
Author Interviews, Heart Disease, Lipids / 08.01.2026

[caption id="attachment_71964" align="alignleft" width="256"]Ask T. Nordestgaard, MD PhDPostdoctoral research fellow Division of Preventive Medicine Brigham and Women's Hospital Boston, MA 02215 Dr. Nordestgaard[/caption] MedicalResearch.com Interview with: Ask T. Nordestgaard, MD PhD Postdoctoral research fellow Division of Preventive Medicine Brigham and Women's Hospital Boston, MA 02215   MedicalResearch.com: What is the background for this study? Response: Elevated Lp(a) is associated with high risk of CVD in multiple cohorts. We have recently shown that Lp(a) in the highest quintile is associated with 30-year risk of CVD; however, among healthy individuals, these results may be driven only by those with very extreme Lp(a) levels (e.g., above the 99th percentile). Therefore, in this follow-up study, we examined associations between various clinical thresholds of Lp(a) and CVD across 30 years of follow-up among apparently healthy women.
Author Interviews, Diabetes, Heart Disease, Kidney Disease / 18.12.2025

MedicalResearch.com Interview with: [caption id="attachment_71837" align="alignleft" width="150"]dr_kramer_headshot Dr. Holly Kramer[/caption] Dr. Holly Kramer MD, MPH Professor of Public Health Sciences and Medicine Division of Nephrology and Hypertension Loyola University Chicago MedicalResearch.com: What is the background for this survey? How is UACR measured? Would you explain the significance of albumin in the urine and what creatinine represents? Response: Approximately 36 million people live with type 2 diabetes (T2D) in the U.S. today, with cardiovascular disease (CVD) being the number one cause of death for this patient population. About 1 in 3 adults with T2D has UACR >30 mg/g with prevalence approaching 40% in older patients. Compared to patients with T2D alone, those with elevated UACR face:
    • 5-times higher risk of hospitalization for heart failure
    • 4-times higher risk of CV mortality
    • 3-times higher risk of myocardial infarction
Interestingly, once thought of as a traditional renal biomarker, urine albumin-to-creatinine ratio (UACR) >30 is also a critical biomarker and urgent signal of cardiovascular (CV) risk. When checking UACR, we look at two things: the amount of albumin leaking into the urine and the creatinine level. Albumin shouldn’t be getting through the kidneys’ filters at all, so when we see a UACR >30 mg/g, it’s a sign of systemic vascular endothelial dysfunction. So, if albumin is leaking through the blood vessels inside the kidneys, there’s also damage in the vessels across other organs, like the heart. UACR is such an important early indicator of CV risk in T2D because even small increases follow a clear ‘rule of three’s’. Healthy kidneys secrete 3 mg/g of albumin to creatinine per day, but when it rises to 30 mg/g, a tenfold increase that signals vascular dysfunction and increasing CV risk. At 300 mg/g, another tenfold increase, the damage is more advanced, and CV risk accelerates. Patients with eGFR >60 BUT UACR >30 mg/g can have up to 3.6 times increased risk of CV mortality. As a nephrologist, I’ve been vocal about the potential for this common urine test that we regularly perform, a UACR test, in helping detect CV risk, not just kidney damage, in more patients.
Author Interviews, Heart Disease / 12.12.2025

MedicalResearch.com Interview with: [caption id="attachment_71774" align="alignleft" width="150"] Prof. Fairbairn[/caption] Prof. Timothy Fairbairn MBChB, PhD FRCP  and [caption id="attachment_71775" align="alignleft" width="150"] Dr. Bell[/caption] Dr.  Jack Bell Liverpool Heart and Chest Hospital Liverpool, UK   MedicalResearch.com: What is the background for this study? Response: Coronary computed tomography angiography (CCTA) is a non-invasive heart scan used in the first-line investigation of patients with suspected stable coronary artery disease (CAD). While CCTA clearly shows blockages in coronary arteries, it is limited in its ability to estimate reduced blood flow, which is necessary to diagnose angina. An artificial intelligence-based tool (Heartflow) has been developed that analyses CCTA images and provides an estimate of blood flow: CT-derived fractional flow reserve (FFR-CT). The real-world, retrospective English FISH&CHIPS study demonstrated that including FFR-CT as a decision-making tool in the diagnosis of stable CAD reduces the number of subsequent invasive and non-invasive tests performed. Whether FFR-CT could also be used prognostically, to predict future major cardiovascular events, was not fully understood. Previous studies have had small patient numbers, short follow-up and investigated combined cardiovascular outcomes. We performed an analysis on the national FISH&CHIPS population, which was large enough to determine if FFR-CT adds incremental value to traditional cardiovascular risk factors in predicting cardiovascular outcomes and death.
Author Interviews, Genetic Research, Heart Disease / 14.08.2025

MedicalResearch.com Interview with: [caption id="attachment_70301" align="alignleft" width="92"]Takeshi Tsuda, MDSenior Pediatric Cardiologist Nemours Cardiac Center Nemours Children’s Health Delaware Dr. Tsuda[/caption] Takeshi Tsuda, MD Senior Pediatric Cardiologist Nemours Cardiac Center Nemours Children’s Health Delaware MedicalResearch.com: What is the background for this study?  Would you briefly explain the condition of Duchenne Muscular Dystrophy? Response: Duchenne muscular dystrophy (DMD) is a genetic muscle disorder causing progressive muscle weakness and wasting, resulting in severe disability during childhood due to absence of dystrophin protein in the muscle cells. Cardiac disease (cardiomyopathy) also develops during early adolescence, potentially leading to heart failure. Because of its insidious progression, the onset of DMD cardiomyopathy is not clearly identified. Early treatment is essential for better outcomes, but the recognition of the preclinical stages of disease is challenging. MedicalResearch.com: Is Unrelieved Wall Stress a commonly recognized echocardiogram finding? Response: Duchenne muscular dystrophy cardiomyopathy is a unique myocardial abnormality caused by the absence of dystrophin, which serves not only as a cytoskeletal protein to maintain cellular integrity but also as a mechano-sensor to adjust wall stress to normalize myocardial oxygen demand. Dystrophin deficiency results in lack of these functions, resulting in rapid myocyte death without compensatory response to normalize wall stress. By our methods, we are able to identify the unrelieved wall stress (increase in iWS) as an early sign of DMD cardiomyopathy before visible ventricular dysfunction prevails, not by the known routine approach.
Heart Disease, Personalized Medicine / 27.03.2025

[caption id="attachment_67598" align="aligncenter" width="500"]personalized-cardiology-care-Dr-Marshall Photo by Pavel Danilyuk[/caption] Sponsored post How we treat heart disease remains a major health concern in today's fast-pace world. More healthcare professionals are turning to personalized, prevention-based care as medical tools improve and our understanding of cardiovascular risk grows. An example of that change is interventional cardiologist Dr. Robert Marshall, who is known for his clinical expertise but also for his patient-centered approach. Building a Strong Foundation Dr. Marshall has spent years refining his approach to cardiology, combining traditional medical training with deep knowledge in nutrition. This background gives him a unique, holistic perspective when it comes to heart health. But what truly makes his care stand out is how he adapts his knowledge to fit the individual needs of each patient.
Author Interviews, Heart Disease, OBGYNE / 05.02.2025

MedicalResearch.com Interview with: [caption id="attachment_66370" align="alignleft" width="200"]Cande V. Ananth PhD MPH Professor and Vice Chair for Academic Affairs Chief, Division of Epidemiology and Biostatistics Department of Obstetrics, Gynecology, and Reproductive Sciences Rutgers Robert Wood Johnson Medical School, NJ Editor-in-Chief, Paediatric and Perinatal Epidemiology Prof. Ananth[/caption] Cande V. Ananth PhD MPH Professor and Vice Chair for Academic Affairs Chief, Division of Epidemiology and Biostatistics Department of Obstetrics, Gynecology, and Reproductive Sciences Rutgers Robert Wood Johnson Medical School, NJ Editor-in-Chief, Paediatric and Perinatal Epidemiology   MedicalResearch.com: What is the background for this study? Response: The rate of twin pregnancies worldwide has risen in recent decades, driven by fertility treatments and older maternal ages. MedicalResearch.com: What are the main findings? Response: Compared to singleton pregnancies with normal blood pressure, people with twins with normal blood pressure were around twice as likely to be hospitalized with cardiovascular disease. For those with twins with high blood pressure during pregnancy, the risk was more than eight times higher. 
Heart Disease, Legal-Malpractice, Women's Heart Health / 13.12.2024

[caption id="attachment_65475" align="aligncenter" width="500"]heart-disease-in-women Pexels Image[/caption] Heart attacks are not just a male health issue. Every year, 30,000 women in the UK are admitted to hospital after having a heart attack. Despite this, women are 50% more likely than men to receive an incorrect initial diagnosis, delaying critical care. The most common heart attack symptom for both sexes is chest pain or discomfort that doesn’t subside. However, women often experience additional symptoms that can easily be missed, such as:
  • Pain radiating to the jaw, neck, back, stomach, or arms.
  • Nausea, dizziness, or feeling faint.
Clinicians unfamiliar with these gender-specific differences may misinterpret these symptoms as being unrelated to the heart. Tragically, women whose heart attacks are missed at first have a 70% higher risk of dying compared to those promptly diagnosed.
Author Interviews, COVID -19 Coronavirus, Heart Disease / 10.10.2024

MedicalResearch.com Interview with: [caption id="attachment_63906" align="alignleft" width="160"]Stanley Hazen, MD, PhDChair, Cardiovascular & Metabolic Sciences  Lerner Research Institute CoSection head, Preventive Cardiology & Cardiovascular Rehabilitation  Heart, Vascular and Thoracic Institute Cleveland Clinic Dr. Hazen[/caption] Stanley Hazen, MD, PhD Chair, Cardiovascular & Metabolic Sciences Lerner Research Institute CoSection head, Preventive Cardiology & Cardiovascular Rehabilitation Heart, Vascular and Thoracic Institute Cleveland Clinic MedicalResearch.com: What is the background for this study? Response:  One of the unique features of COVID is that in some subjects, there unfortunately appear to be long term adverse effects that can occur following resolution of the acute infection.  These studies add to the growing body of data showing that COVID-19 infection can enhance risk for experiencing adverse cardiac events (heart attack, stroke, and death) over time.
Author Interviews, Heart Disease, JAMA, Lipids / 03.07.2024

MedicalResearch.com Interview with: [caption id="attachment_62223" align="alignleft" width="150"]Evan A Stein MD PhD FACCCOO/CSO LIB Therapeutics Cincinnati. OH USA 45227 Dr. Stein[/caption] Evan A Stein MD PhD FACC COO/CSO LIB Therapeutics Cincinnati. OH USA 45227 MedicalResearch.com: What is the background for this study? Response: Cardiovascular disease (CVD) remains the main cause of morbidity and mortality worldwide and is increasing in rapidly industrializing countries and is projected to cause more than >20 million deaths annually over the next 15 years. Low-density lipoprotein cholesterol (LDL-C) is well established as a major, easily modifiable, risk factor for CVD. Reductions with statins and, more recently, PCSK9 inhibitors, all agents which directly or indirectly upregulate the LDL receptor and enhance LDL-C clearance, have demonstrated CVD event reductions in cardiovascular outcome trials. Extensive data from these trials, provide a rough estimate that every 40 mg/dL reduction in LDL-C will reduce the risk of major CV cardiovascular events by 22% to 24%. Furthermore, trials with PCSK9 inhibitors added to statins which achieve substantial additional LDL-C reduction show and CVD event reduction remains linear to very low LDL-C levels without signals of adverse events. Based on this body of evidence, recent revisions to national and international guidelines, now advocate for greater LDL-C reductions and lower LDL-C treatment goals, for patients not achieving these goals on statins alone. The current consensus target goal for LDL-C in patients with CVD, or who are at very-high risk for of CVD, is now less than <55 mg/dL, and <70 mg/dL for those at high risk. This global trial of over 900 patients with CVD, or at very or high risk for CVD, on maximally tolerated statins assessed the 52-week efficacy and safety of monthly lerodalcibep.
Heart Disease, Technology / 07.03.2024

Heart disease remains a leading cause of morbidity and mortality worldwide. Despite advances in medical technology and treatment modalities, managing heart disease remains challenging. This is particularly true in remote or underserved areas with limited access to specialized healthcare. However, remote patient monitoring (RPM) has transformed the landscape of cardiac care, offering innovative solutions for proactive management and early intervention. The market for remote patient monitoring was projected to be valued at $14.0 billion in 2023, according to PR Newswire. By 2028, it is anticipated to increase to $41.7 billion. This article explores the significance of remote patient monitoring in effectively managing heart disease and its evolving role in enhancing patient outcomes.
AHA Journals, Author Interviews, Biomarkers, Brigham & Women's - Harvard, Heart Disease / 27.02.2024

MedicalResearch.com Interview with: [caption id="attachment_61359" align="alignleft" width="150"]Dr. Hoshi Dr. Hoshi[/caption] Rosangela Akemi Hoshi, Ph.D. Lemann Foundation Cardiovascular Research Postdoctoral Fellowship Center for Lipid Metabolomics Divisions of Preventive and Cardiovascular Medicine Brigham and Women's Hospital Boston, MA  MedicalResearch.com: What is the background for this study? Would you describe the IgG N-glycan profile? Response: Glycans are sugar coatings of proteins, made of monosaccharide building blocks, that are involved in a variety of biological pathways.  Different sugar structures can dictate or modify the protein’s activity through specific interactions with cellular receptors. For example, proteins lacking glycans have a reduced level or a complete loss of function. Glycans are of such importance that the 2022 Nobel Prize in chemistry was awarded for glycan-based science. In this study, we examined glycans attached to Immunoglobulins G (IgG) and their link with incidence of cardiovascular disease (CVD) due to their impact on IgG inflammatory properties. Since inflammation is not only a cause, but also an aggravating factor and a mediator of a worse prognosis in cardiometabolic disorders and CVD, we investigated whether different glycan structures may characterize an at-risk phenotype for CVD development. Determining glycan profiles involved in multiple conditions can serve prognostic and diagnostic purposes. Yet, unlike other types of macromolecules, glycans are still not as much explored, characterizing a promising but underappreciated class that should be further investigated.
Heart Disease, Pediatrics / 06.10.2023

If you’re a worried or concerned parent looking to learn more about vascular ring, the following guide has information you need. This includes:
  • Vascular ring definition
  • Causes and symptoms
  • How the treatment of vascular ring works
By the end, you’ll be feeling much calmer with your new knowledge.

What Is Vascular Ring?

Vascular ring is a heart defect that’s present from birth. A part of the body’s main artery forms a small ring around the trachea (windpipe) or esophagus (the pipe that connects the throat to the stomach). In some cases, the ring can occur around both the trachea and the esophagus, but this is less common. Compared with other congenital heart defects, vascular ring is one of the rare ones. As of today, vascular rings are incredibly rare and occur in less than 1% of babies.
Author Interviews, Heart Disease, JAMA, Statins / 09.03.2023

[caption id="attachment_60153" align="alignleft" width="150"]Myeong-Ki Hong, MD PhDProfessor of Cardiology
Yonsei University College of Medicine
Severance Cardiovascular Hospital
Seoul, Korea Prof. Myeong-Ki Hong[/caption] MedicalResearch.com Interview with: Myeong-Ki Hong, MD PhD Professor of Cardiology Yonsei University College of Medicine Severance Cardiovascular Hospital Seoul, Korea MedicalResearch.com: What is the background for this study? Response: The background of this study was to compare the long-term clinical outcomes between the two distinct strategies regarding statin intensity in patients with coronary artery disease (CAD). One is to titrate statin intensity to meet a target low-density lipoprotein cholesterol (LDL-C) level (treat-to-target strategy), the other is to maintain high-intensity statin without a target goal (high-intensity statin strategy).
Author Interviews, Heart Disease, Race/Ethnic Diversity / 28.02.2023

MedicalResearch.com Interview with: [caption id="attachment_60103" align="alignleft" width="125"]Dr. Muchi Ditah Chobufo MD MPHCardiology Fellow West Virginia University Dr. Ditah Chobufo[/caption] Dr. Muchi Ditah Chobufo MD MPH Cardiology Fellow West Virginia University MedicalResearch.com: What is the background for this study? Response: Ischemic heart diseases are a significant cause of morbidity and mortality in the USA. Also, there exists alarming ethnic disparities in mortality rates following acute myocardial infarction. To this effect, significant efforts have been deployed over the years to curb its burden and reduce extant disparities. It is in this light that we set out to analyze general and ethnic specific trends in acute myocardial infarction related age adjusted mortality rates (AAMR) in the entire USA from 1999-2020. 
Author Interviews, Cost of Health Care, Heart Disease, JACC / 26.02.2023

MedicalResearch.com Interview with: [caption id="attachment_60080" align="alignleft" width="150"]Rishi K. Wadhera, MD, MPP, MPhilSection Head, Health Policy and Equity,
Richard A. and Susan F. Smith Center for Outcomes Research
Associate Program Director, Cardiovascular Medicine Fellowship at Beth Israel Deaconess Medical Center
Assistant Professor of Medicine,
Harvard Medical School Dr. Wadhera[/caption] Rishi K. Wadhera, MD, MPP, MPhil Section Head, Health Policy and Equity, Richard A. and Susan F. Smith Center for Outcomes Research Associate Program Director Cardiovascular Medicine Fellowship at Beth Israel Deaconess Medical Center Assistant Professor of Medicine, Harvard Medical School @rkwadhera MedicalResearch.com: What is the background for this study? Response: High and rising prescription drug costs in the United States contribute to medication non-adherence and financial strain among adults with cardiovascular risk factors or disease. As a result, addressing prescription drug costs in patients with chronic conditions has become a national priority. In response to these growing concerns, federal policymakers passed the Inflation Reduction Act on August 16, 2022, which aims to address high out-of-pocket drug costs for adults enrolled in Medicare Part D, by placing a $2000 annual cap on out-of-pocket prescription drug costs and expanding eligibility for full low-income subsidies to individuals that reduce deductible costs and prescription copayments (among several other provisions). It is unclear how these provisions will affect Medicare beneficiaries with cardiovascular risk factors and/or conditions.
Author Interviews, Biomarkers, Heart Disease, JACC, University of Michigan / 21.12.2022

MedicalResearch.com Interview with: [caption id="attachment_59873" align="alignleft" width="130"]Salim S. Hayek MDAssistant Professor
Medical Director of the Frankel Cardiovascular Center Clinics
University of Michigan Dr. Hayek[/caption] Salim S. Hayek MD Assistant Professor Medical Director of the Frankel Cardiovascular Center Clinics University of Michigan MedicalResearch.com: What is the background for this study? What are the main findings? Response: Essentially, immune checkpoint myocarditis is a rare but deadly complication of immune checkpoint inhibitors – amazing drugs that are increasingly used for the treatment of various cancers. Most patients present late, and when they do, they’re very ill and have a 50% chance of death. Diagnosing ICI myocarditis is challenging, given there is no one test that can differentiate it from other causes of cardiac injury. It is important to diagnose it fast, early and accurately in order to start immunosuppressive therapy as soon as possible. What we did in this study was look at commonly measured biomarkers in all patients receiving ICI at the University of Michigan. What we found was that patients who developed ICI myocarditis had early signs of muscle destruction (rise in CPK) levels and hepatitis (rise in AST, ALT), and that all patients who had myocarditis with bad outcomes had rises in all of the aforementioned biomarkers. Creatinine phosphokinase was the most sensitive.
Author Interviews, Heart Disease, JACC, Supplements / 06.12.2022

MedicalResearch.com Interview with: [caption id="attachment_59776" align="alignleft" width="200"]Simin Liu MD MPH ScDProfessor of Epidemiology at the School of Public Health, Professor of Medicine (Endocrinology) and Professor of Surgery at the Alpert School of Medicine Brown University Dr. Simin Liu[/caption] Simin Liu MD MPH ScD Professor of Epidemiology at the School of Public Health, Professor of Medicine (Endocrinology) and Professor of Surgery at the Alpert School of Medicine Brown University MedicalResearch.com: What is the background for this study? Response: Our research team has been researching the roles of environmental and genetic determinants of chronic diseases for nearly three decades, with special emphasis on evaluating micronutrients, minerals, and trace elements in relation to cardiometabolic outcomes, and findings of which have contributed to the design of several large, randomized trials of dietary supplements in the US (Liu JAMA 1999; 2011; Diabetes Care 2005a,b; Diabetes 2006).  Several large intervention trials have consistently shown beneficial effects on clinical cardiometabolic outcomes of a diet pattern rich in micronutrients, although research on micronutrient supplementation has mainly focused on the health effects of a single or a few vitamins and minerals. We decided to take a comprehensive and systematic approach to evaluate all the publicly available/accessible studies reporting all micronutrients including phytochemicals and antioxidant supplements and their effects on cardiovascular risk factors as well as multiple CVDs.
Aging, Author Interviews, Brigham & Women's - Harvard, Dermatology, Heart Disease, Herpes Viruses, Stroke / 23.11.2022

MedicalResearch.com Interview with:| [caption id="attachment_59757" align="alignleft" width="133"]Sharon G. Curhan, MD, ScM| Dr. Curhan[/caption] Sharon G. Curhan, MD, ScM| Director, CHEARS: The Conservation of Hearing Study Channing Division of Network Medicine Department of Medicine Brigham and Women’s Hospital Harvard Medical School Boston, MA 02114 MedicalResearch.com: What is the background for this study? Response:       Herpes zoster, commonly known as “shingles,” is a viral infection that often causes a painful rash. Shingles can occur anywhere on the head or body. Shingles is caused by the varicella zoster virus (VZV), the same virus that causes chickenpox. After a person has chickenpox, the virus stays in their body for the rest of their life. Years and even decades later, the virus may reactivate as shingles. Almost all individuals age 50 years and older in the US have been infected with the varicella zoster virus and therefore they are at risk for shingles. About 1 in 3 people will develop shingles during their lifetime, and since age is a risk factor for shingles, this number may increase as the population ages. The risk is also higher among individuals of any age who are immunocompromised due to disease or treatment. A number of serious complications can occur when a person develops shingles, such as post-herpetic neuralgia (long-lasting pain), but there was limited information on whether there are other adverse long-term health implications of developing shingles. There is a growing body of evidence that links VZV, the virus that causes shingles, to vascular disease. VZV vasculopathy may cause damage to blood vessels and increase the risk of stroke or coronary heart disease. Although some previous studies showed a higher risk of stroke or heart attack around the time of the shingles infection, it was not known whether this higher risk persisted in the long term. Therefore, the question we aimed to address in this study was to investigate whether shingles is associated with higher long-term risk of stroke or coronary heart disease. To address this question, we conducted a prospective longitudinal study in 3 large US cohorts of >200,000 women and men, the Nurses’ Health Study (>79,000 women), the Nurses’ Health Study II (almost 94,000 women) and the Health Professionals Follow-Up Study (>31,000 men), without a prior history of stroke or coronary heart disease. We collected information on shingles, stroke and coronary heart disease on biennial questionnaires and confirmed the diagnoses with medical record review. We followed the participants for up to 16 years and evaluated whether those who had developed shingles were at higher risk for stroke or coronary heart disease years after the shingles episode. The outcomes we measured were incident stroke, incident coronary heart disease [defined as having a non-fatal or fatal myocardial infarction (heart attack) or a coronary revascularization procedure (CABG, coronary artery bypass graft or percutaneous transluminal coronary angioplasty)]. We also evaluated a combined outcome of cardiovascular disease, which included either stroke or coronary heart disease, whichever came first.
Author Interviews, Heart Disease, JAMA, Primary Care, Stroke, USPSTF / 06.09.2022

MedicalResearch.com Interview with: [caption id="attachment_59503" align="alignleft" width="150"]Katrina E. Donahue, M.D., M.P.H. Professor and Vice Chair of Research Chapel Hill Department of Family Medicine University of North Carolina Dr. Donahue joined the U.S. Preventive Services Task Force in January 2020. Dr. Donahue[/caption] Katrina E. Donahue, M.D., M.P.H. Professor and Vice Chair of Research Chapel Hill Department of Family Medicine University of North Carolina Dr. Donahue joined the U.S. Preventive Services Task Force in January 2020. MedicalResearch.com: What is the background for this study? What are the main findings? Response: Heart disease and stroke are the leading causes of death in the U.S. The Task Force found that people who are 40 to 75 years old and at high risk for heart disease should take a statin to help protect their health. People in this age group who are at increased risk but not high risk should make an individual decision with their healthcare professional about whether taking a statin is right for them. There is not enough research to determine whether statins are beneficial for people 76 years and older.
Author Interviews, Heart Disease, NEJM / 30.08.2022

MedicalResearch.com Interview with: [caption id="attachment_59461" align="alignleft" width="128"]Dr Holly Morgan M.B., B.Ch. Clinical Research Fellow and REVIVED investigator King's College London Dr. Morgan[/caption] Dr Holly Morgan M.B., B.Ch. Clinical Research Fellow and REVIVED investigator King's College London MedicalResearch.com: What is the background for this study? Response: Coronary artery disease is the commonest cause of heart failure.  Whilst individually tailored pharmacological and device therapy (optimal medical therapy, OMT) is the cornerstone of management of ischemic heart failure, rates of death and hospitalization for heart failure remain unacceptably high in this population.  Given the causative relationship between coronary disease and heart failure, coronary revascularization has long been considered as a treatment option for these patients.  Whilst there is randomized evidence to support surgical revascularization with coronary artery bypass grafting (1), none previously existed for percutaneous coronary intervention (PCI) in stable ischemic left ventricular dysfunction. Despite this, patients are frequently offered PCI in this setting (particularly if unsuitable for surgery); driven by the belief that hibernating myocardium will improve in function if blood flow is restored, regardless of the revascularization method.  This approach was supported in some international guidelines, though recommendations varied. The REVIVED-BCIS2 trial aimed to establish whether revascularization with PCI in addition to OMT would improve event free survival in patients with ischemic left ventricular dysfunction, when compared to OMT alone (2).  Inclusion criteria included a left ventricular ejection fraction of ≤35%, extensive coronary artery disease (British Cardiovascular Intervention Society jeopardy score ≥6, indicating significant stenoses in the left main coronary artery, proximal left anterior descending coronary artery, dominant circumflex artery, disease in multiple vessels or a combination of these) and viability in at least four dysfunctional myocardial segments which were amenable to PCI.  The main exclusion criteria were acute myocardial infarction within 4 weeks of randomisation, angina which limited the patient’s quality of life or decompensated heart failure or sustained ventricular arrhythmia within 72 hours. The primary composite outcome was all-cause death or hospitalization for heart failure; minimum follow up was 24 months.  Key secondary outcomes included the change in left ventricular ejection fraction from baseline to follow-up at six and twelve months, myocardial infarction, unplanned revascularization and quality of life assessed with the Kansas City Cardiomyopathy Questionnaire and EQ-5D-5L.
Author Interviews, Heart Disease, Menopause / 05.08.2022

MedicalResearch.com Interview with: Jean Shin Department of Family Medicine Korea University College of Medicine Seoul,Republic of Korea

MedicalResearch.com: What is the background for this study?

Response: Younger age at menopause is a possible risk factor for cardiovascular diseases. However, data on the association among premature menopause, age at menopause, and the risk of heart failure and atrial fibrillation are lacking. We aimed to examine the association of premature menopause and age at menopause with the risk of heart failure and atrial fibrillation. 

Author Interviews, Heart Disease, Salt-Sodium / 20.07.2022

MedicalResearch.com Interview with Weihao Liang on behalf of Professor Chen Liu Department of Cardiology, Sun Yat-sen University First Affiliated Hospital Guangzhou, Guangdong, China MedicalResearch.com:  What is the background for this study?    Response: -Salt intake restriction is frequently recommended in heart failure guidelines, but is restricting salt intake to "as least as possible" appropriate? Evidence is lacking. Besides, the effect of salt restriction on patients with heart failure with preserved ejection fraction isn’t clear as they have often been excluded from relevant studies.
Author Interviews, Gender Differences, Heart Disease, JACC, Surgical Research / 06.04.2022

MedicalResearch.com Interview with: [caption id="attachment_58987" align="alignleft" width="200"]Left: Mario Gaudino, MD PhD; Right: Antonino Di Franco, MD Left: Mario Gaudino, MD PhD; Right: Antonino Di Franco, MD[/caption] Mario F.L. Gaudino, M.D. PhD Attending Cardiac SurgeonDepartment of Cardiothoracic Surgery Antonino Di Franco, MD Adjunct Clinical Assistant Professor of Cardiothoracic Surgery Weill Cornell Medicine   MedicalResearch.com:  What is the background for this study?  What is the aim of this review?  Response: Biological and socio-cultural differences between men and women are complex and likely account for most of the variations in the epidemiology and treatment outcomes of coronary artery disease (CAD) between the two sexes. Despite the growing recognition of sex-specific determinants of outcomes, representation of women in clinical studies remains low, and sex-specific management strategies are generally not provided in guidelines. We summarized the current evidence on sex-related differences in patients with CAD, focusing on the differential outcomes following medical therapy, percutaneous coronary interventions, and coronary artery bypass surgery.